Literature DB >> 28698903

[Optimal fractionation regimen, and time between radiotherapy and operation in rectal cancer : The multicenter, randomized Stockholm III trial].

Emmanouil Fokas1, Claus Rödel2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28698903     DOI： 10.1007/s00066-017-1181-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  7 in total

1.  Impact of the interval between short-course radiotherapy and surgery on outcomes of rectal cancer patients.

Authors:  Colette B M van den Broek; Thomas A Vermeer; Esther Bastiaannet; Harm J T Rutten; Cornelis J H van de Velde; Corrie A M Marijnen
Journal:  Eur J Cancer       Date:  2013-06-22       Impact factor: 9.162

2.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial.

Authors:  Willem van Gijn; Corrie A M Marijnen; Iris D Nagtegaal; Elma Meershoek-Klein Kranenbarg; Hein Putter; Theo Wiggers; Harm J T Rutten; Lars Påhlman; Bengt Glimelius; Cornelis J H van de Velde
Journal:  Lancet Oncol       Date:  2011-05-17       Impact factor: 41.316

3.  Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study.

Authors:  K Bujko; L Wyrwicz; A Rutkowski; M Malinowska; L Pietrzak; J Kryński; W Michalski; J Olędzki; J Kuśnierz; L Zając; M Bednarczyk; M Szczepkowski; W Tarnowski; E Kosakowska; J Zwoliński; M Winiarek; K Wiśniowska; M Partycki; K Bęczkowska; W Polkowski; R Styliński; R Wierzbicki; P Bury; M Jankiewicz; K Paprota; M Lewicka; B Ciseł; M Skórzewska; J Mielko; M Bębenek; A Maciejczyk; B Kapturkiewicz; A Dybko; Ł Hajac; A Wojnar; T Leśniak; J Zygulska; D Jantner; E Chudyba; W Zegarski; M Las-Jankowska; M Jankowski; L Kołodziejski; A Radkowski; U Żelazowska-Omiotek; B Czeremszyńska; L Kępka; J Kolb-Sielecki; Z Toczko; Z Fedorowicz; A Dziki; A Danek; G Nawrocki; R Sopyło; W Markiewicz; P Kędzierawski; J Wydmański
Journal:  Ann Oncol       Date:  2016-02-15       Impact factor: 32.976

4.  Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial.

Authors:  Per J Nilsson; Boudewijn van Etten; Geke A P Hospers; Lars Påhlman; Cornelis J H van de Velde; Regina G H Beets-Tan; Lennart Blomqvist; Jannet C Beukema; Ellen Kapiteijn; Corrie A M Marijnen; Iris D Nagtegaal; Theo Wiggers; Bengt Glimelius
Journal:  BMC Cancer       Date:  2013-06-07       Impact factor: 4.430

5.  Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer--treatment results at 5-year follow-up.

Authors:  Radoslaw Pach; Jan Kulig; Piotr Richter; Tomasz Gach; Miroslaw Szura; Teresa Kowalska
Journal:  Langenbecks Arch Surg       Date:  2011-12-15       Impact factor: 3.445

6.  Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer.

Authors:  D Pettersson; E Lörinc; T Holm; H Iversen; B Cedermark; B Glimelius; A Martling
Journal:  Br J Surg       Date:  2015-07       Impact factor: 6.939

7.  Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

Authors:  David Sebag-Montefiore; Richard J Stephens; Robert Steele; John Monson; Robert Grieve; Subhash Khanna; Phil Quirke; Jean Couture; Catherine de Metz; Arthur Sun Myint; Eric Bessell; Gareth Griffiths; Lindsay C Thompson; Mahesh Parmar
Journal:  Lancet       Date:  2009-03-07       Impact factor: 79.321
  7 in total
  2 in total

1.  A treatment planning study of prone vs. supine positions for locally advanced rectal carcinoma : Comparison of 3‑dimensional conformal radiotherapy, tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy.

Authors:  Sergiu Scobioala; Christopher Kittel; Philipp Niermann; Heidi Wolters; Katharina Helene Susek; Uwe Haverkamp; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2018-05-31       Impact factor: 3.621

2.  The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.

Authors:  Tarkan Jäger; Daniel Neureiter; Mohammad Fallaha; Philipp Schredl; Tobias Kiesslich; Romana Urbas; Eckhard Klieser; Josef Holzinger; Felix Sedlmayer; Klaus Emmanuel; Adam Dinnewitzer
Journal:  Strahlenther Onkol       Date:  2018-08-01       Impact factor: 3.621
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.